Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917747 · ClinicalTrials.gov registry record · NA
Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators
A NA study, sponsored by Matthew Bush, MD.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01917747: Completed NA study, sponsored by Matthew Bush, MD.
NCT01917747 is a NA study that has completed, run by Matthew Bush, MD. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01917747, a NA study, has completed, sponsored by Matthew Bush, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.
Primary Outcome
This outcome is the number of participants who do not follow-up for diagnostic audiologic testing after a failed newborn hearing screening from the date of randomization to 3 months after birth.
Interventions
- BEHAVIORAL Patient Navigator
- BEHAVIORAL Standard scheduling and follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
What the finished NCT01917747 record still lists
NCT01917747 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Patient Navigator is the first listed.
NCT01917747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01917747 about?
NCT01917747 is a clinical study titled "Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators". Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed tes...
What is the current status of trial NCT01917747?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-01-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT01917747?
The interventions under investigation include: Patient Navigator (BEHAVIORAL), Standard scheduling and follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT01917747?
This trial is sponsored by Matthew Bush, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01917747's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI